Literature DB >> 15465038

TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways.

Takemi Akahane1, Manabu Akahane, Amy Shah, Unnur P Thorgeirsson.   

Abstract

Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a multifunctional protein, which is found in most tissues and body fluids. Here, we demonstrated that recombinant TIMP-1 but not the synthetic matrix metalloproteinase inhibitor, GM6001, stimulated proliferation of human aortic smooth muscle cells (AoSMC) in a dose-dependent manner. The mitogenic effect was associated with activation of Ras, increased phosphorylation of ERK, and stimulation of cyclin D1 expression. The phosphatidylinositol 3-kinase (PI3K) signaling pathway was also involved since the PI3K inhibitor, LY294002, abolished the TIMP-1-mediated growth stimulation. These data suggest that TIMP-1 activates Ras, which then turns on the ERK and PI3K signaling pathways to promote cell cycle progression of the AoSMC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465038     DOI: 10.1016/j.bbrc.2004.09.063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition.

Authors:  Merry L Lindsey; Andriy Yabluchanskiy; Yonggang Ma
Journal:  Cardiology       Date:  2015-08-01       Impact factor: 1.869

Review 2.  Cytokine functions of TIMP-1.

Authors:  Christian Ries
Journal:  Cell Mol Life Sci       Date:  2013-08-28       Impact factor: 9.261

3.  The genetic basis of Turner syndrome aortopathy.

Authors:  Holly Corbitt; Jacob Gutierrez; Michael Silberbach; Cheryl L Maslen
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-02-16       Impact factor: 3.908

4.  Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression.

Authors:  Yang Lu; Shuxin Liu; Shujia Zhang; Guangyan Cai; Hongwei Jiang; Huabin Su; Xiaofan Li; Quan Hong; Xueguang Zhang; Xiangmei Chen
Journal:  Mol Cells       Date:  2011-01-06       Impact factor: 5.034

5.  Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study.

Authors:  John W Gaubatz; Christie M Ballantyne; Bruce A Wasserman; Max He; Lloyd E Chambless; Eric Boerwinkle; Ron C Hoogeveen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-18       Impact factor: 8.311

6.  Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis.

Authors:  Jacek Rysz; Maciej Banach; Robert A Stolarek; Dimitri P Mikhailidis; Aleksandra Cialkowska-Rysz; Lech Pokoca; Mariusz Piechota; Zbigniew Baj
Journal:  Int Urol Nephrol       Date:  2009-12-02       Impact factor: 2.370

Review 7.  The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2.

Authors:  William G Stetler-Stevenson
Journal:  Cancer Metastasis Rev       Date:  2008-03       Impact factor: 9.264

8.  Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer.

Authors:  Hsiu-Pei Tsai; Shin-Cheh Chen; Huei-Tzu Chien; Yi-Yin Jan; Tzu-Chieh Chao; Miin-Fu Chen; Ling-Ling Hsieh
Journal:  World J Surg Oncol       Date:  2012-02-17       Impact factor: 2.754

9.  Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases.

Authors:  Anna Ónody; Apor Veres-Székely; Domonkos Pap; Réka Rokonay; Beáta Szebeni; Erna Sziksz; Franz Oswald; Gábor Veres; Áron Cseh; Attila J Szabó; Ádám Vannay
Journal:  J Transl Med       Date:  2021-06-02       Impact factor: 5.531

10.  TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.

Authors:  Line S Tarpgaard; Maj Sofie Ørum-Madsen; Ib J Christensen; Cathrine Nordgaard; Julie Noer; Tormod K Guren; Bengt Glimelius; Halfdan Sorbye; Tone Ikdahl; Elin H Kure; Kjell M Tveit; Hans J Nielsen; Per Pfeiffer; Nils Brünner; José M A Moreira
Journal:  Oncotarget       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.